StockGlow

Cingulate Inc. (CINGW)

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.

$0.01+0.00%
Compare CINGW with
StockGlow Score
100
Bullish
BearishBullish
1 year ago-76.7%

The outlook

Cingulate Inc. currently reads as bullish based on 100% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

52-week range100% of the way from its 52-week low to high
Market cap
—
52-wk high
$0.01
52-wk low
$0.01
50-day avg
—
200-day avg
—
Trailing P/E
—

Similar stocks

CINGCingulate Inc.$4.77+0.11%CELUWCelularity Inc.$0.00+533.33%DRMAWDermata Therapeutics, Inc.$0.01-32.38%NRSNWNeuroSense Therapeutics Ltd.$0.10+0.00%DRTSWAlpha Tau Medical Ltd.$2.62-2.96%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy